Drug resistance makes treatment difficult in
cancers. The present study identifies and analyzes drug resistance-related
miRNA in
colorectal cancer. We established 4 types of
5-fluorouracil (5-FU)-resistant
colon cancer cell lines in vitro and in vivo. We then analyzed the
miRNA expression profile by
miRNA array in these 4 cell lines, and identified the drug resistance-related
miRNAs. We examined the expression levels of the identified
miRNA in 112
colorectal tumor samples from the patients. We identified 12 possible
miRNAs involved in
5-FU resistance by
miRNA arrays. We then examined the relationship between miR-31, which was the most promising among them, and drug resistance. The ectopic expression of mimic miR-31 showed significant
5-FU resistance in the parental DLD-1 cells, while anti-miR-31 caused significant growth inhibition in DLD/F cells; that is, 5-FU-resistant
colon cancer cell line DLD-1 under exposure to
5-FU. When we exposed high doses of
5-FU to parent or 5-FU-resistant cells, the expression levels of miR-31 were raised higher than those of controls. Notably, the expression levels of miR-31 were positively correlated with the grade of clinical stages of
colorectal tumors. The
protein expression levels of factors inhibiting
hypoxia-inducible factor 1 were downregulated by transfection of mimic miR-31 into DLD-1 cells. This study provides evidence supporting the association of miR-31 with
5-FU drug resistance and clinical stages of
colorectal tumors.